Global Stock News

Moderna Stock Drops After Morgan Stanley Sticks To Neutral Rating Despite Lifting Price Target

Moderna Stock Drops After Morgan Stanley Sticks To Neutral Rating Despite Lifting Price Target

Key Stats for Moderna Stock

  • Price change for Moderna stock: -7%
  • $MRNA Stock Price as of Jul. 8: $74
  • 52-Week High: $86
  • $MRNA Stock Price Target: $48

Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>

What Happened?

Moderna (MRNA) stock dropped 7% today after Morgan Stanley reiterated its “equal-weight” rating on the company. That rating essentially means the firm isn’t strongly bullish or bearish; it’s a neutral stance.

What’s interesting is that Morgan Stanley actually raised its price target on Moderna stock to $39 from $33, an 18% bump, citing higher expectations for the company’s COVID and flu vaccine sales.

So why would…

Source link

Share this article

Scroll to Top